The Patent Finder

Iteos Therapeutics S.A.

Also on record
Records under this name other than the patents Iteos Therapeutics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Iteos Therapeutics S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,995,1012-Oxo-Thiazole Derivatives as A2A Inhibitors and Compounds for Use in the Treatment of Cancers
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,329,349Anti-Tigit Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,439,705Anti-Tigit Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,427,594Non Brain Penetrant A2A Inhibitors and Methods for Use in the Treatment of Cancers
Formerly held
Lapsed on the fee record
Ended Aug 30, 2026 · High confidence
Lapsed on the fee recordEnded Aug 30, 2026High confidence
US 11,376,255Thiocarbamate Derivatives as A2A Inhibitors, Pharmaceutical Composition Thereof and Combinations with Anticancer Agents
Formerly held
Lapsed on the fee record
Ended Jul 5, 2026 · High confidence
Lapsed on the fee recordEnded Jul 5, 2026High confidence
US 9,949,951Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors
Lapsed on the fee record
Ended Apr 24, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 24, 2026USPTO record
US 10,945,994Combinations Comprising a PYRROLIDINE-2,5-Dione IDO1 Inhibitor and an Anti-Body
Lapsed on the fee record
Ended Mar 16, 2025 · High confidence
Lapsed on the fee recordEnded Mar 16, 2025High confidence
US 10,398,679Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors
Lapsed on the fee record
Ended Sep 3, 2023 · USPTO record
Lapsed on the fee recordEnded Sep 3, 2023USPTO record
US 9,873,690Novel 3-Indol Substituted Derivatives, Pharmaceutical Compositions and Methods for Use
Lapsed on the fee record
Ended Jan 23, 2022 · High confidence
Lapsed on the fee recordEnded Jan 23, 2022High confidence
US 9,758,5053-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
Lapsed on the fee record
Ended Sep 12, 2021 · USPTO record
Lapsed on the fee recordEnded Sep 12, 2021USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited